亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC

医学 内科学 阶段(地层学) 突变体 肿瘤科 癌症研究 病理 生物 基因 遗传学 古生物学
作者
Hyun Ae Jung,Jinyeong Lim,Yoon‐La Choi,Se‐Hoon Lee,Je‐Gun Joung,Yeong Jeong Jeon,Jae Won Choi,Sumin Shin,Jong Ho Cho,Hong Kwan Kim,Yong Soo Choi,Jae Ill Zo,Young Mog Shim,Sehhoon Park,Jong‐Mu Sun,Jin Seok Ahn,Myung‐Ju Ahn,Joungho Han,Woong‐Yang Park,Jhingook Kim
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:28 (19): 4312-4321 被引量:22
标识
DOI:10.1158/1078-0432.ccr-22-0879
摘要

PURPOSE: In early-stage, EGFR mutation-positive (EGFR-M+) non-small cell lung cancer (NSCLC), surgery remains the primary treatment, without personalized adjuvant treatments. We aimed to identify risk factors for recurrence-free survival (RFS) to suggest personalized adjuvant strategies in resected early-stage EGFR-M+ NSCLC. EXPERIMENTAL DESIGN: From January 2008 to August 2020, a total of 2,340 patients with pathologic stage (pStage) IB-IIIA, non-squamous NSCLC underwent curative surgery. To identify clinicopathologic risk factors, 1,181 patients with pStage IB-IIIA, common EGFR-M+ NSCLC who underwent surgical resection were analyzed. To identify molecular risk factors, comprehensive genomic analysis was conducted in 56 patients with matched case-controls (pStage II and IIIA and type of EGFR mutation). RESULTS: Median follow-up duration was 38.8 months (0.5-156.2). Among 1,181 patients, pStage IB, II, and IIIA comprised 577 (48.9%), 331 (28.0%), and 273 (23.1%) subjects, respectively. Median RFS was 73.5 months [95% confidence interval (CI), 62.1-84.9], 48.7 months (95% CI, 41.2-56.3), and 22.7 months (95% CI, 19.4-26.0) for pStage IB, II, and IIIA, respectively (P < 0.001). In multivariate analysis of clinicopathologic risk factors, pStage, micropapillary subtype, vascular invasion, and pleural invasion, and pathologic classification by cell of origin (type II pneumocyte-like tumor cell vs. bronchial surface epithelial cell-like tumor cell) were associated with RFS. As molecular risk factors, the non-terminal respiratory unit (non-TRU) of the RNA subtype (HR, 3.49; 95% CI, 1.72-7.09; P < 0.01) and TP53 mutation (HR, 2.50; 95% CI, 1.24-5.04; P = 0.01) were associated with poor RFS independent of pStage II or IIIA. Among the patients with recurrence, progression-free survival of EGFR-tyrosine kinase inhibitor (TKI) in those with the Apolipoprotein B mRNA Editing Catalytic Polypeptide-like (APOBEC) mutation signature was inferior compared with that of patients without this signature (8.6 vs. 28.8 months; HR, 4.16; 95% CI, 1.28-13.46; P = 0.02). CONCLUSIONS: The low-risk group with TRU subtype and TP53 wild-type without clinicopathologic risk factors might not need adjuvant EGFR-TKIs. In the high-risk group, with non-TRU subtype and/or TP 53 mutation, or clinicopathologic risk factors, a novel adjuvant strategy of EGFR-TKI with others, e.g., chemotherapy or antiangiogenic agents needs to be investigated. Given the poor outcome to EGFR-TKIs after recurrence in patients with the APOBEC mutation signature, an alternative adjuvant strategy might be needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
魔幻雅柔完成签到,获得积分10
刚刚
月亮打烊完成签到 ,获得积分10
3秒前
文静楷瑞完成签到,获得积分10
6秒前
fx完成签到 ,获得积分10
8秒前
8秒前
fantasy的应助被十三采纳,获得10
9秒前
深情安青的应助被outlast采纳,获得10
14秒前
十三完成签到,获得积分10
15秒前
16秒前
20秒前
拼搏问薇完成签到 ,获得积分10
21秒前
22秒前
Abcqqq完成签到 ,获得积分10
22秒前
海洋球完成签到,获得积分10
24秒前
ll完成签到,获得积分20
24秒前
小蘑菇的应助被xx2026采纳,获得10
25秒前
26秒前
kxz完成签到 ,获得积分10
26秒前
27秒前
gale发布了新的文献求助10
30秒前
红墨发布了新的文献求助30
31秒前
33秒前
怕黑的驳完成签到,获得积分10
34秒前
36秒前
37秒前
38秒前
39秒前
吐司发布了新的文献求助10
40秒前
冷静新烟完成签到,获得积分10
40秒前
gale完成签到,获得积分10
43秒前
48秒前
48秒前
TIDUS完成签到,获得积分10
50秒前
独特的念柏完成签到,获得积分10
54秒前
sadascaqwqw发布了新的文献求助10
54秒前
36hours完成签到,获得积分10
55秒前
田様的应助被冷静新烟采纳,获得10
55秒前
56秒前
Ava的应助被典雅的可乐采纳,获得10
1分钟前
赘婿的应助被胡图图不糊涂采纳,获得10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195004
求助须知:如何正确求助?哪些是违规求助? 9580729
关于积分的说明 21872554
捐赠科研通 7794720
什么是DOI,文献DOI怎么找? 3437836
关于科研通互助平台的介绍 2561159
邀请新用户注册赠送积分活动 2484541